Entity Details

Primary name HBG2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP69892
EntryNameHBG2_HUMAN
FullNameHemoglobin subunit gamma-2
TaxID9606
Evidenceevidence at protein level
Length147
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesHBG2

GO terms

Show/Hide Table
GOName
GO:0005344 oxygen carrier activity
GO:0005829 cytosol
GO:0005833 hemoglobin complex
GO:0007596 blood coagulation
GO:0019825 oxygen binding
GO:0020037 heme binding
GO:0031721 hemoglobin alpha binding
GO:0031838 haptoglobin-hemoglobin complex
GO:0042744 hydrogen peroxide catabolic process
GO:0043177 organic acid binding
GO:0046872 metal ion binding
GO:0072562 blood microparticle
GO:0098869 cellular oxidant detoxification

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR000971 GlobinDomainDomain
IPR002337 Haemoglobin, beta-typeFamilyFamily
IPR009050 Globin-like superfamilyFamilyHomologous superfamily
IPR012292 Globin/ProtoglobinFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613977 OMIMCyanosis transient neonatal (TNCY)A disorder characterized by cyanosis in the fetus and neonate, due to a defect in the fetal hemoglobin chain which has reduced affinity for oxygen. Some patients develop anemia resulting from increased destruction of red cells containing abnormal or unstable hemoglobin. The cyanosis resolves spontaneously by 5 to 6 months of age or earlier, as the adult beta-globin chain is produced and replaces the fetal gamma-globin chain. The disease is caused by variants affecting the gene represented in this entry.